Liquidia Corporation (LQDA) reported second-quarter 2026 financial results, including total revenue of $171.7 million and net income of $74.7 million, or $0.84 per basic share and $0.74 per diluted share. Product sales, net, were $170.4 million for the quarter ended June 30, 2026.
The company said YUTREPIA net product sales rose 31% from the first quarter of 2026. Liquidia also reported approximately 5,900 unique patient prescriptions and more than 5,000 patients treated between launch in June 2025 and July 31, 2026.
- Cash and cash equivalents totaled $284.2 million as of June 30, 2026, compared with $190.7 million as of Dec. 31, 2025.
- Research and development expenses were $17.2 million, up from $6.0 million a year earlier.
- Selling, general and administrative expenses were $57.4 million, compared with $38.8 million in the prior-year quarter.
- Liquidia said it is progressing 10 clinical studies supporting YUTREPIA and L606 across known and new indications for inhaled treprostinil.
- The company will host a webcast on Aug. 12, 2026, to discuss results and provide a corporate update.
$LQDA Insider Trading Activity
$LQDA insiders have traded $LQDA stock on the open market 117 times in the past 6 months. Of those trades, 1 have been purchases and 116 have been sales.
Here’s a breakdown of recent trading of $LQDA stock by insiders over the last 6 months:
- STEPHEN M BLOCH has made 0 purchases and 48 sales selling 1,757,692 shares for an estimated $118,662,601.
- ROGER JEFFS (Chief Executive Officer) has made 0 purchases and 21 sales selling 486,565 shares for an estimated $24,914,862.
- MICHAEL KASETA (CFO and COO) has made 0 purchases and 9 sales selling 339,388 shares for an estimated $14,243,260.
- PAUL B MANNING has made 0 purchases and 5 sales selling 200,000 shares for an estimated $12,782,058.
- SCOTT MOOMAW (Chief Commercial Officer) has made 0 purchases and 7 sales selling 118,400 shares for an estimated $4,586,119.
- SARAH KREPP (Chief Human Resource Officer) has made 0 purchases and 5 sales selling 37,301 shares for an estimated $2,485,739.
- RAMAN SINGH sold 29,494 shares for an estimated $1,773,435
- RUSSELL SCHUNDLER (General Counsel) has made 0 purchases and 3 sales selling 28,430 shares for an estimated $1,579,287.
- RAJEEV SAGGAR (Chief Medical Officer) has made 0 purchases and 3 sales selling 19,146 shares for an estimated $1,063,587.
- DANA BOYLE (Chief Accounting Officer) has made 0 purchases and 5 sales selling 17,279 shares for an estimated $1,039,054.
- JASON ADAIR (Chief Business Officer) has made 0 purchases and 5 sales selling 16,540 shares for an estimated $931,303.
- PARTNERS LP CALIGAN has made 1 purchase buying 5,300 shares for an estimated $317,894 and 1 sale selling 5,300 shares for an estimated $317,894.
- SANJEEV KHINDRI (Chief Development Officer) has made 0 purchases and 3 sales selling 5,319 shares for an estimated $355,351.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$LQDA Hedge Fund Activity
We have seen 177 institutional investors add shares of $LQDA stock to their portfolio, and 108 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 5,299,442 shares (+96.5%) to their portfolio in Q2 2026, for an estimated $422,524,510
- TCG CROSSOVER MANAGEMENT, LLC removed 1,307,036 shares (-76.4%) from their portfolio in Q1 2026, for an estimated $49,327,538
- STATE STREET CORP added 1,148,796 shares (+61.1%) to their portfolio in Q2 2026, for an estimated $91,593,505
- PRICE T ROWE ASSOCIATES INC /MD/ added 916,040 shares (+2468.4%) to their portfolio in Q1 2026, for an estimated $34,571,349
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 738,975 shares (+281.9%) to their portfolio in Q1 2026, for an estimated $27,888,916
- FINDELL CAPITAL MANAGEMENT LLC added 650,663 shares (+22.8%) to their portfolio in Q1 2026, for an estimated $24,556,021
- CITADEL ADVISORS LLC removed 649,182 shares (-81.1%) from their portfolio in Q1 2026, for an estimated $24,500,128
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
